BioPharm News

BioPharm International: Mar 06, 2015
In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Mar 06, 2015
By BioPharm International Editors
Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.
Mar 05, 2015
By BioPharm International Editors
AbbVie’s acquisition of Pharmacyclics establishes the combined company as an emerging leader in hematological oncology.
Mar 04, 2015
By BioPharm International Editors
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.
Mar 03, 2015
By BioPharm International Editors
Canon announced that it established Canon BioMedical, a wholly owned biomedical business to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform.
BioPharm International: Mar 03, 2015
By BioPharm International Editors
The upgrades will offer the opportunity for higher product yields and higher purity levels.
Feb 27, 2015
By BioPharm International Editors
FDA announced that it would postpone a meeting that would be critical for the advancement of Celltrion’s Remicade biosimilar in the US.
BioPharm International: Feb 25, 2015
Remsima will now be available for patients in 12 additional countries in the European Union.
BioPharm International: Feb 24, 2015
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.